News

Hungary summoned the Ukrainian ambassador on Thursday, after a report that a Hungarian-Ukrainian dual citizen was beaten to death during forced mobilisation, an allegation Ukraine's army rejected, ...
Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company ...
Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.
Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days in May, Dr Aurélie Dehaene, radiologist at European Hospital in Marseille, ...
Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device exemption study was ...
The trial evaluates the Hēlo™ PE Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism (PE)—a life-threatening condition caused by blood clots in the lungs.
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism Multi-center, multi-national study builds on ...
A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors.